Thursday | Nov 14 2024 |
This approval allows Lupin to market a generic equivalent of Merck Sharp & Dohme’s Isentress HD Tablets, 600 mg, which are used in HIV-1 treatment
Subscribe to our newsletter to get updates on our latest news